Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$155.97 - $200.09 $4.54 Million - $5.82 Million
-29,080 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $2.73 Million - $3.52 Million
-15,062 Reduced 34.12%
29,080 $5.48 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $435,745 - $482,706
-2,302 Reduced 4.96%
44,142 $8.57 Million
Q2 2021

Aug 13, 2021

BUY
$155.9 - $187.99 $1.46 Million - $1.77 Million
9,391 Added 25.34%
46,444 $8.66 Million
Q1 2021

May 13, 2021

BUY
$144.0 - $169.39 $976,896 - $1.15 Million
6,784 Added 22.41%
37,053 $5.84 Million
Q4 2020

Feb 12, 2021

BUY
$157.07 - $174.35 $4.48 Million - $4.97 Million
28,503 Added 1613.99%
30,269 $5.01 Million
Q3 2020

Nov 13, 2020

BUY
$137.1 - $165.37 $118,728 - $143,210
866 Added 96.22%
1,766 $292,000
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $100,728 - $128,277
-900 Reduced 50.0%
900 $123,000
Q1 2020

May 15, 2020

SELL
$92.66 - $144.94 $389,172 - $608,748
-4,200 Reduced 70.0%
1,800 $212,000
Q4 2019

Feb 13, 2020

SELL
$116.25 - $133.25 $232,500 - $266,500
-2,000 Reduced 25.0%
6,000 $794,000
Q3 2019

Nov 06, 2019

BUY
$112.57 - $128.43 $337,710 - $385,290
3,000 Added 60.0%
8,000 $997,000
Q2 2019

Aug 09, 2019

SELL
$97.98 - $114.28 $97,980 - $114,280
-1,000 Reduced 16.67%
5,000 $567,000
Q1 2019

May 13, 2019

BUY
$81.56 - $100.67 $244,680 - $302,010
3,000 Added 100.0%
6,000 $604,000
Q4 2018

Feb 12, 2019

BUY
$79.28 - $95.27 $237,840 - $285,810
3,000 New
3,000 $257,000
Q2 2018

Aug 14, 2018

SELL
$79.9 - $89.2 $319,600 - $356,800
-4,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$71.51 - $84.69 $286,040 - $338,760
4,000 New
4,000 $334,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.3B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Permanens Capital L.P. Portfolio

Follow Permanens Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Permanens Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Permanens Capital L.P. with notifications on news.